New Orleans Hosts Psychedelic Research Conference Double-Header
Over the last week in February, more than 200 people from psychedelic drug development companies, clinical researchers, regulators, and investors gathered in New Orleans to attend the 6th Annual Psychedelic Therapeutics and Drug Development Conference (PTDD) and the 3rd meeting of the International Society for Psychedelic Research (ISRP). The post New Orleans Hosts Psychedelic Research Conference Double-Header first appeared on Lucid News. The post New Orleans Hosts Psychedelic Research Conference Double-Header appeared first on Lucid News.
External link. We are not responsible for the content.
Read more ↗More From Lucid News
Psychedelic Policy Briefing 8.21.26
Resilient Pharmaceuticals (formerly Lykos Therapeutics and MAPS PBC), reportedly resubmitted their once-rejected New ...
Weekly Psychedelic Policy Briefing – August 14, 2026
The FDA has finalized guidance on clinical investigations into psychedelic-assisted therapies and contract research o...
Psychedelic Policy Briefing
In this week's psychedelic policy briefing, investigative journalist Jack Gorsline unpacks a wave of state and federa...
Latest News
Why Most Drugs Fail, and Why Virtual Tissue Models Beat Virtual Cell Models
Welcome back to Business Trip by PsyMed Ventures, a podcast exploring the future of mental health & wellness!
Ibogaine’s Momentum Is Real. So Is the Safety Gap Nobody’s Solving.
Recent reporting, has documented a string of serious adverse events at overseas psychedelic clinics such as cardiac d...
Was Carlos Castaneda Among the First Psychedelic Grifters?
Author Carlos Castaneda built a fortune on a fabricated Indigenous lineage. A new biography shows how his blueprint s...
University of Miami’s Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science
Washington, D.C., August 25, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS)has welcomed the ...
Who Gets to Heal?
A donor gift with no diagnosis requirement forced a debate inside Thank You Life. Its executive director asks whether...
Weekly Psychedelic Policy Briefing: August 23, 2026
Oregon's psilocybin program posted its first real-world outcome data this week, just as regulators move on fee increa...